Atea Pharmaceuticals, Inc. (AVIR) NASDAQ
6.13
+0.08000006(+1.32%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.13
+0.08000006(+1.32%)
Currency In USD
| Market Cap | 290.94M |
| Enterprise Value | 196.07M |
| P/E Ratio | -3.02 |
| PEG Ratio | 0.31 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.74 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.5 |
| Return On Equity | -0.46 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -416,000 |
| EBITDA | -180.89M |
| Net Income | -158.35M |
| Diluted EPS | -1.94 |
| Total Cash | 301.83M |
| Total Cash/Share | 3.86 |
| Total Debt | 843,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.82 |
| Book Value Per Share | 3.53 |
| 52-Week Change | 95.85 |
| 52-Week High | 6.45 |
| 52-Week Low | 2.46 |
| Moving Average 50 Days | 4.44 |
| Moving Average 200 Days | 3.58 |
| Average Volume | 548,393 |
| Shares Outstanding | 79.67M |
| % Held by Institutions | 72.11 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |